GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of ... (med that GSK has begun building a manufa...)

GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program

Date:12/4/2008

med that GSK has begun building a manufacturing line that will result in a four-fold increase in the current global capacity to produce albendazole tablets. The new facility, to be built in Nashik, India, will enable GSK to produce more that 600 million tablets a year by 2010. GSK will invest nearly pounds Sterling 200,000 (approximately $300,000) in the facility as well as convert existing equipment to produce the tablets. This dramatic increase in capacity will improve the lives of over 550 million people in India who live at risk of developing this debilitating condition, which currently costs India an estimated $840 million each year due to treatment costs and reduced working time.

About lymphatic filariasis - Lymphatic filariasis, often called elephantiasis, is a parasitic infection spread by mosquitoes that causes grotesque, painful swelling of the limbs, breasts, and genitals. Considered a neglected tropical disease, LF almost exclusively affects the world's poorest people. Approximately one fifth of the world's population (1.3 billion people) is at risk of contracting LF and approximately 120 million people in 83 countries are currently infected.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com

The Carter Center - A not-for-profit, nongovernmental organization, The Carter Center has helped to improve life for people in more than 70 countries by resolving conflicts; advancing democracy, human rights, and economic opportunity; preventing diseases; improving mental health care; and teaching farmers in developing nations to increase crop production. The Carter Center was founded in 1982 by former U.S. President Jimmy
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
2. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
3. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
4. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
5. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
6. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
7. GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
8. IADR and GlaxoSmithKline Consumer Healthcare announce winners
9. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
10. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
11. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting

Post Your Comments:

GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of ...(med that GSK has begun building a manufa...),Health